Global Sirolimus Eluting Coronary Stent Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 109

Published Date: 11 May 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Sirolimus Eluting Coronary Stent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Sirolimus Eluting Coronary Stent market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Hospitals accounting for % of the Sirolimus Eluting Coronary Stent global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Balloon Diameter 2.25-3 mm segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Sirolimus Eluting Coronary Stent include Cardionovum, Concept Medical, BIOTRONIK, Terumo Europe, and Meril Life Sciences, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Sirolimus Eluting Coronary Stent market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Balloon Diameter 2.25-3 mm
    Balloon Diameter 3-4 mm
    Others

Market segment by Application can be divided into
    Hospitals
    Clinics
    Others

The key market players for global Sirolimus Eluting Coronary Stent market are listed below:
    Cardionovum
    Concept Medical
    BIOTRONIK
    Terumo Europe
    Meril Life Sciences
    eucatech AG
    Eurocor Tech
    MedAlliance
    Boston Scientific
    Abbott
    Vasmed
    Alvimedica
    B. Braun
    Balton

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sirolimus Eluting Coronary Stent product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sirolimus Eluting Coronary Stent, with price, sales, revenue and global market share of Sirolimus Eluting Coronary Stent from 2019 to 2022.
Chapter 3, the Sirolimus Eluting Coronary Stent competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sirolimus Eluting Coronary Stent breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sirolimus Eluting Coronary Stent market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sirolimus Eluting Coronary Stent.
Chapter 13, 14, and 15, to describe Sirolimus Eluting Coronary Stent sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Sirolimus Eluting Coronary Stent Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Sirolimus Eluting Coronary Stent Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Balloon Diameter 2.25-3 mm
        1.2.3 Balloon Diameter 3-4 mm
        1.2.4 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Sirolimus Eluting Coronary Stent Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Sirolimus Eluting Coronary Stent Market Size & Forecast
        1.4.1 Global Sirolimus Eluting Coronary Stent Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Sirolimus Eluting Coronary Stent Sales in Volume (2017-2028)
        1.4.3 Global Sirolimus Eluting Coronary Stent Price (2017-2028)
    1.5 Global Sirolimus Eluting Coronary Stent Production Capacity Analysis
        1.5.1 Global Sirolimus Eluting Coronary Stent Total Production Capacity (2017-2028)
        1.5.2 Global Sirolimus Eluting Coronary Stent Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Sirolimus Eluting Coronary Stent Market Drivers
        1.6.2 Sirolimus Eluting Coronary Stent Market Restraints
        1.6.3 Sirolimus Eluting Coronary Stent Trends Analysis

2 Manufacturers Profiles
    2.1 Cardionovum
        2.1.1 Cardionovum Details
        2.1.2 Cardionovum Major Business
        2.1.3 Cardionovum Sirolimus Eluting Coronary Stent Product and Services
        2.1.4 Cardionovum Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Concept Medical
        2.2.1 Concept Medical Details
        2.2.2 Concept Medical Major Business
        2.2.3 Concept Medical Sirolimus Eluting Coronary Stent Product and Services
        2.2.4 Concept Medical Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 BIOTRONIK
        2.3.1 BIOTRONIK Details
        2.3.2 BIOTRONIK Major Business
        2.3.3 BIOTRONIK Sirolimus Eluting Coronary Stent Product and Services
        2.3.4 BIOTRONIK Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Terumo Europe
        2.4.1 Terumo Europe Details
        2.4.2 Terumo Europe Major Business
        2.4.3 Terumo Europe Sirolimus Eluting Coronary Stent Product and Services
        2.4.4 Terumo Europe Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Meril Life Sciences
        2.5.1 Meril Life Sciences Details
        2.5.2 Meril Life Sciences Major Business
        2.5.3 Meril Life Sciences Sirolimus Eluting Coronary Stent Product and Services
        2.5.4 Meril Life Sciences Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 eucatech AG
        2.6.1 eucatech AG Details
        2.6.2 eucatech AG Major Business
        2.6.3 eucatech AG Sirolimus Eluting Coronary Stent Product and Services
        2.6.4 eucatech AG Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Eurocor Tech
        2.7.1 Eurocor Tech Details
        2.7.2 Eurocor Tech Major Business
        2.7.3 Eurocor Tech Sirolimus Eluting Coronary Stent Product and Services
        2.7.4 Eurocor Tech Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 MedAlliance
        2.8.1 MedAlliance Details
        2.8.2 MedAlliance Major Business
        2.8.3 MedAlliance Sirolimus Eluting Coronary Stent Product and Services
        2.8.4 MedAlliance Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Boston Scientific
        2.9.1 Boston Scientific Details
        2.9.2 Boston Scientific Major Business
        2.9.3 Boston Scientific Sirolimus Eluting Coronary Stent Product and Services
        2.9.4 Boston Scientific Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Abbott
        2.10.1 Abbott Details
        2.10.2 Abbott Major Business
        2.10.3 Abbott Sirolimus Eluting Coronary Stent Product and Services
        2.10.4 Abbott Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Vasmed
        2.11.1 Vasmed Details
        2.11.2 Vasmed Major Business
        2.11.3 Vasmed Sirolimus Eluting Coronary Stent Product and Services
        2.11.4 Vasmed Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Alvimedica
        2.12.1 Alvimedica Details
        2.12.2 Alvimedica Major Business
        2.12.3 Alvimedica Sirolimus Eluting Coronary Stent Product and Services
        2.12.4 Alvimedica Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 B. Braun
        2.13.1 B. Braun Details
        2.13.2 B. Braun Major Business
        2.13.3 B. Braun Sirolimus Eluting Coronary Stent Product and Services
        2.13.4 B. Braun Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Balton
        2.14.1 Balton Details
        2.14.2 Balton Major Business
        2.14.3 Balton Sirolimus Eluting Coronary Stent Product and Services
        2.14.4 Balton Sirolimus Eluting Coronary Stent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Sirolimus Eluting Coronary Stent Breakdown Data by Manufacturer
    3.1 Global Sirolimus Eluting Coronary Stent Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Sirolimus Eluting Coronary Stent Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Sirolimus Eluting Coronary Stent
    3.4 Market Concentration Rate
        3.4.1 Top 3 Sirolimus Eluting Coronary Stent Manufacturer Market Share in 2021
        3.4.2 Top 6 Sirolimus Eluting Coronary Stent Manufacturer Market Share in 2021
    3.5 Global Sirolimus Eluting Coronary Stent Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Sirolimus Eluting Coronary Stent Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Sirolimus Eluting Coronary Stent Market Size by Region
        4.1.1 Global Sirolimus Eluting Coronary Stent Sales in Volume by Region (2017-2028)
        4.1.2 Global Sirolimus Eluting Coronary Stent Revenue by Region (2017-2028)
    4.2 North America Sirolimus Eluting Coronary Stent Revenue (2017-2028)
    4.3 Europe Sirolimus Eluting Coronary Stent Revenue (2017-2028)
    4.4 Asia-Pacific Sirolimus Eluting Coronary Stent Revenue (2017-2028)
    4.5 South America Sirolimus Eluting Coronary Stent Revenue (2017-2028)
    4.6 Middle East and Africa Sirolimus Eluting Coronary Stent Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Sirolimus Eluting Coronary Stent Sales in Volume by Type (2017-2028)
    5.2 Global Sirolimus Eluting Coronary Stent Revenue by Type (2017-2028)
    5.3 Global Sirolimus Eluting Coronary Stent Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Sirolimus Eluting Coronary Stent Sales in Volume by Application (2017-2028)
    6.2 Global Sirolimus Eluting Coronary Stent Revenue by Application (2017-2028)
    6.3 Global Sirolimus Eluting Coronary Stent Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Sirolimus Eluting Coronary Stent Sales by Type (2017-2028)
    7.2 North America Sirolimus Eluting Coronary Stent Sales by Application (2017-2028)
    7.3 North America Sirolimus Eluting Coronary Stent Market Size by Country
        7.3.1 North America Sirolimus Eluting Coronary Stent Sales in Volume by Country (2017-2028)
        7.3.2 North America Sirolimus Eluting Coronary Stent Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Sirolimus Eluting Coronary Stent Sales by Type (2017-2028)
    8.2 Europe Sirolimus Eluting Coronary Stent Sales by Application (2017-2028)
    8.3 Europe Sirolimus Eluting Coronary Stent Market Size by Country
        8.3.1 Europe Sirolimus Eluting Coronary Stent Sales in Volume by Country (2017-2028)
        8.3.2 Europe Sirolimus Eluting Coronary Stent Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Sirolimus Eluting Coronary Stent Sales by Type (2017-2028)
    9.2 Asia-Pacific Sirolimus Eluting Coronary Stent Sales by Application (2017-2028)
    9.3 Asia-Pacific Sirolimus Eluting Coronary Stent Market Size by Region
        9.3.1 Asia-Pacific Sirolimus Eluting Coronary Stent Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Sirolimus Eluting Coronary Stent Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Sirolimus Eluting Coronary Stent Sales by Type (2017-2028)
    10.2 South America Sirolimus Eluting Coronary Stent Sales by Application (2017-2028)
    10.3 South America Sirolimus Eluting Coronary Stent Market Size by Country
        10.3.1 South America Sirolimus Eluting Coronary Stent Sales in Volume by Country (2017-2028)
        10.3.2 South America Sirolimus Eluting Coronary Stent Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Sirolimus Eluting Coronary Stent Sales by Type (2017-2028)
    11.2 Middle East & Africa Sirolimus Eluting Coronary Stent Sales by Application (2017-2028)
    11.3 Middle East & Africa Sirolimus Eluting Coronary Stent Market Size by Country
        11.3.1 Middle East & Africa Sirolimus Eluting Coronary Stent Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Sirolimus Eluting Coronary Stent Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Sirolimus Eluting Coronary Stent and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Sirolimus Eluting Coronary Stent
    12.3 Sirolimus Eluting Coronary Stent Production Process
    12.4 Sirolimus Eluting Coronary Stent Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Sirolimus Eluting Coronary Stent Typical Distributors
    13.3 Sirolimus Eluting Coronary Stent Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Sirolimus Eluting Coronary Stent Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Sirolimus Eluting Coronary Stent Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Cardionovum Basic Information, Manufacturing Base and Competitors
    Table 4. Cardionovum Major Business
    Table 5. Cardionovum Sirolimus Eluting Coronary Stent Product and Services
    Table 6. Cardionovum Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Concept Medical Basic Information, Manufacturing Base and Competitors
    Table 8. Concept Medical Major Business
    Table 9. Concept Medical Sirolimus Eluting Coronary Stent Product and Services
    Table 10. Concept Medical Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. BIOTRONIK Basic Information, Manufacturing Base and Competitors
    Table 12. BIOTRONIK Major Business
    Table 13. BIOTRONIK Sirolimus Eluting Coronary Stent Product and Services
    Table 14. BIOTRONIK Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Terumo Europe Basic Information, Manufacturing Base and Competitors
    Table 16. Terumo Europe Major Business
    Table 17. Terumo Europe Sirolimus Eluting Coronary Stent Product and Services
    Table 18. Terumo Europe Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Meril Life Sciences Basic Information, Manufacturing Base and Competitors
    Table 20. Meril Life Sciences Major Business
    Table 21. Meril Life Sciences Sirolimus Eluting Coronary Stent Product and Services
    Table 22. Meril Life Sciences Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. eucatech AG Basic Information, Manufacturing Base and Competitors
    Table 24. eucatech AG Major Business
    Table 25. eucatech AG Sirolimus Eluting Coronary Stent Product and Services
    Table 26. eucatech AG Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Eurocor Tech Basic Information, Manufacturing Base and Competitors
    Table 28. Eurocor Tech Major Business
    Table 29. Eurocor Tech Sirolimus Eluting Coronary Stent Product and Services
    Table 30. Eurocor Tech Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. MedAlliance Basic Information, Manufacturing Base and Competitors
    Table 32. MedAlliance Major Business
    Table 33. MedAlliance Sirolimus Eluting Coronary Stent Product and Services
    Table 34. MedAlliance Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Boston Scientific Basic Information, Manufacturing Base and Competitors
    Table 36. Boston Scientific Major Business
    Table 37. Boston Scientific Sirolimus Eluting Coronary Stent Product and Services
    Table 38. Boston Scientific Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Abbott Basic Information, Manufacturing Base and Competitors
    Table 40. Abbott Major Business
    Table 41. Abbott Sirolimus Eluting Coronary Stent Product and Services
    Table 42. Abbott Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. Vasmed Basic Information, Manufacturing Base and Competitors
    Table 44. Vasmed Major Business
    Table 45. Vasmed Sirolimus Eluting Coronary Stent Product and Services
    Table 46. Vasmed Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 47. Alvimedica Basic Information, Manufacturing Base and Competitors
    Table 48. Alvimedica Major Business
    Table 49. Alvimedica Sirolimus Eluting Coronary Stent Product and Services
    Table 50. Alvimedica Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 51. B. Braun Basic Information, Manufacturing Base and Competitors
    Table 52. B. Braun Major Business
    Table 53. B. Braun Sirolimus Eluting Coronary Stent Product and Services
    Table 54. B. Braun Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 55. Balton Basic Information, Manufacturing Base and Competitors
    Table 56. Balton Major Business
    Table 57. Balton Sirolimus Eluting Coronary Stent Product and Services
    Table 58. Balton Sirolimus Eluting Coronary Stent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 59. Global Sirolimus Eluting Coronary Stent Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
    Table 60. Global Sirolimus Eluting Coronary Stent Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 61. Market Position of Manufacturers in Sirolimus Eluting Coronary Stent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 62. Global Sirolimus Eluting Coronary Stent Production Capacity by Company, (K Units): 2020 VS 2021
    Table 63. Head Office and Sirolimus Eluting Coronary Stent Production Site of Key Manufacturer
    Table 64. Sirolimus Eluting Coronary Stent New Entrant and Capacity Expansion Plans
    Table 65. Sirolimus Eluting Coronary Stent Mergers & Acquisitions in the Past Five Years
    Table 66. Global Sirolimus Eluting Coronary Stent Sales by Region (2017-2022) & (K Units)
    Table 67. Global Sirolimus Eluting Coronary Stent Sales by Region (2023-2028) & (K Units)
    Table 68. Global Sirolimus Eluting Coronary Stent Revenue by Region (2017-2022) & (USD Million)
    Table 69. Global Sirolimus Eluting Coronary Stent Revenue by Region (2023-2028) & (USD Million)
    Table 70. Global Sirolimus Eluting Coronary Stent Sales by Type (2017-2022) & (K Units)
    Table 71. Global Sirolimus Eluting Coronary Stent Sales by Type (2023-2028) & (K Units)
    Table 72. Global Sirolimus Eluting Coronary Stent Revenue by Type (2017-2022) & (USD Million)
    Table 73. Global Sirolimus Eluting Coronary Stent Revenue by Type (2023-2028) & (USD Million)
    Table 74. Global Sirolimus Eluting Coronary Stent Price by Type (2017-2022) & (US$/Unit)
    Table 75. Global Sirolimus Eluting Coronary Stent Price by Type (2023-2028) & (US$/Unit)
    Table 76. Global Sirolimus Eluting Coronary Stent Sales by Application (2017-2022) & (K Units)
    Table 77. Global Sirolimus Eluting Coronary Stent Sales by Application (2023-2028) & (K Units)
    Table 78. Global Sirolimus Eluting Coronary Stent Revenue by Application (2017-2022) & (USD Million)
    Table 79. Global Sirolimus Eluting Coronary Stent Revenue by Application (2023-2028) & (USD Million)
    Table 80. Global Sirolimus Eluting Coronary Stent Price by Application (2017-2022) & (US$/Unit)
    Table 81. Global Sirolimus Eluting Coronary Stent Price by Application (2023-2028) & (US$/Unit)
    Table 82. North America Sirolimus Eluting Coronary Stent Sales by Country (2017-2022) & (K Units)
    Table 83. North America Sirolimus Eluting Coronary Stent Sales by Country (2023-2028) & (K Units)
    Table 84. North America Sirolimus Eluting Coronary Stent Revenue by Country (2017-2022) & (USD Million)
    Table 85. North America Sirolimus Eluting Coronary Stent Revenue by Country (2023-2028) & (USD Million)
    Table 86. North America Sirolimus Eluting Coronary Stent Sales by Type (2017-2022) & (K Units)
    Table 87. North America Sirolimus Eluting Coronary Stent Sales by Type (2023-2028) & (K Units)
    Table 88. North America Sirolimus Eluting Coronary Stent Sales by Application (2017-2022) & (K Units)
    Table 89. North America Sirolimus Eluting Coronary Stent Sales by Application (2023-2028) & (K Units)
    Table 90. Europe Sirolimus Eluting Coronary Stent Sales by Country (2017-2022) & (K Units)
    Table 91. Europe Sirolimus Eluting Coronary Stent Sales by Country (2023-2028) & (K Units)
    Table 92. Europe Sirolimus Eluting Coronary Stent Revenue by Country (2017-2022) & (USD Million)
    Table 93. Europe Sirolimus Eluting Coronary Stent Revenue by Country (2023-2028) & (USD Million)
    Table 94. Europe Sirolimus Eluting Coronary Stent Sales by Type (2017-2022) & (K Units)
    Table 95. Europe Sirolimus Eluting Coronary Stent Sales by Type (2023-2028) & (K Units)
    Table 96. Europe Sirolimus Eluting Coronary Stent Sales by Application (2017-2022) & (K Units)
    Table 97. Europe Sirolimus Eluting Coronary Stent Sales by Application (2023-2028) & (K Units)
    Table 98. Asia-Pacific Sirolimus Eluting Coronary Stent Sales by Region (2017-2022) & (K Units)
    Table 99. Asia-Pacific Sirolimus Eluting Coronary Stent Sales by Region (2023-2028) & (K Units)
    Table 100. Asia-Pacific Sirolimus Eluting Coronary Stent Revenue by Region (2017-2022) & (USD Million)
    Table 101. Asia-Pacific Sirolimus Eluting Coronary Stent Revenue by Region (2023-2028) & (USD Million)
    Table 102. Asia-Pacific Sirolimus Eluting Coronary Stent Sales by Type (2017-2022) & (K Units)
    Table 103. Asia-Pacific Sirolimus Eluting Coronary Stent Sales by Type (2023-2028) & (K Units)
    Table 104. Asia-Pacific Sirolimus Eluting Coronary Stent Sales by Application (2017-2022) & (K Units)
    Table 105. Asia-Pacific Sirolimus Eluting Coronary Stent Sales by Application (2023-2028) & (K Units)
    Table 106. South America Sirolimus Eluting Coronary Stent Sales by Country (2017-2022) & (K Units)
    Table 107. South America Sirolimus Eluting Coronary Stent Sales by Country (2023-2028) & (K Units)
    Table 108. South America Sirolimus Eluting Coronary Stent Revenue by Country (2017-2022) & (USD Million)
    Table 109. South America Sirolimus Eluting Coronary Stent Revenue by Country (2023-2028) & (USD Million)
    Table 110. South America Sirolimus Eluting Coronary Stent Sales by Type (2017-2022) & (K Units)
    Table 111. South America Sirolimus Eluting Coronary Stent Sales by Type (2023-2028) & (K Units)
    Table 112. South America Sirolimus Eluting Coronary Stent Sales by Application (2017-2022) & (K Units)
    Table 113. South America Sirolimus Eluting Coronary Stent Sales by Application (2023-2028) & (K Units)
    Table 114. Middle East & Africa Sirolimus Eluting Coronary Stent Sales by Region (2017-2022) & (K Units)
    Table 115. Middle East & Africa Sirolimus Eluting Coronary Stent Sales by Region (2023-2028) & (K Units)
    Table 116. Middle East & Africa Sirolimus Eluting Coronary Stent Revenue by Region (2017-2022) & (USD Million)
    Table 117. Middle East & Africa Sirolimus Eluting Coronary Stent Revenue by Region (2023-2028) & (USD Million)
    Table 118. Middle East & Africa Sirolimus Eluting Coronary Stent Sales by Type (2017-2022) & (K Units)
    Table 119. Middle East & Africa Sirolimus Eluting Coronary Stent Sales by Type (2023-2028) & (K Units)
    Table 120. Middle East & Africa Sirolimus Eluting Coronary Stent Sales by Application (2017-2022) & (K Units)
    Table 121. Middle East & Africa Sirolimus Eluting Coronary Stent Sales by Application (2023-2028) & (K Units)
    Table 122. Sirolimus Eluting Coronary Stent Raw Material
    Table 123. Key Manufacturers of Sirolimus Eluting Coronary Stent Raw Materials
    Table 124. Direct Channel Pros & Cons
    Table 125. Indirect Channel Pros & Cons
    Table 126. Sirolimus Eluting Coronary Stent Typical Distributors
    Table 127. Sirolimus Eluting Coronary Stent Typical Customers
List of Figures
    Figure 1. Sirolimus Eluting Coronary Stent Picture
    Figure 2. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Type in 2021
    Figure 3. Balloon Diameter 2.25-3 mm
    Figure 4. Balloon Diameter 3-4 mm
    Figure 5. Others
    Figure 6. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Application in 2021
    Figure 7. Hospitals
    Figure 8. Clinics
    Figure 9. Others
    Figure 10. Global Sirolimus Eluting Coronary Stent Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
    Figure 11. Global Sirolimus Eluting Coronary Stent Revenue and Forecast (2017-2028) & (USD Million)
    Figure 12. Global Sirolimus Eluting Coronary Stent Sales (2017-2028) & (K Units)
    Figure 13. Global Sirolimus Eluting Coronary Stent Price (2017-2028) & (US$/Unit)
    Figure 14. Global Sirolimus Eluting Coronary Stent Production Capacity (2017-2028) & (K Units)
    Figure 15. Global Sirolimus Eluting Coronary Stent Production Capacity by Geographic Region: 2022 VS 2028
    Figure 16. Sirolimus Eluting Coronary Stent Market Drivers
    Figure 17. Sirolimus Eluting Coronary Stent Market Restraints
    Figure 18. Sirolimus Eluting Coronary Stent Market Trends
    Figure 19. Global Sirolimus Eluting Coronary Stent Sales Market Share by Manufacturer in 2021
    Figure 20. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Manufacturer in 2021
    Figure 21. Sirolimus Eluting Coronary Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 22. Top 3 Sirolimus Eluting Coronary Stent Manufacturer (Revenue) Market Share in 2021
    Figure 23. Top 6 Sirolimus Eluting Coronary Stent Manufacturer (Revenue) Market Share in 2021
    Figure 24. Global Sirolimus Eluting Coronary Stent Sales Market Share by Region (2017-2028)
    Figure 25. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Region (2017-2028)
    Figure 26. North America Sirolimus Eluting Coronary Stent Revenue (2017-2028) & (USD Million)
    Figure 27. Europe Sirolimus Eluting Coronary Stent Revenue (2017-2028) & (USD Million)
    Figure 28. Asia-Pacific Sirolimus Eluting Coronary Stent Revenue (2017-2028) & (USD Million)
    Figure 29. South America Sirolimus Eluting Coronary Stent Revenue (2017-2028) & (USD Million)
    Figure 30. Middle East & Africa Sirolimus Eluting Coronary Stent Revenue (2017-2028) & (USD Million)
    Figure 31. Global Sirolimus Eluting Coronary Stent Sales Market Share by Type (2017-2028)
    Figure 32. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Type (2017-2028)
    Figure 33. Global Sirolimus Eluting Coronary Stent Price by Type (2017-2028) & (US$/Unit)
    Figure 34. Global Sirolimus Eluting Coronary Stent Sales Market Share by Application (2017-2028)
    Figure 35. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Application (2017-2028)
    Figure 36. Global Sirolimus Eluting Coronary Stent Price by Application (2017-2028) & (US$/Unit)
    Figure 37. North America Sirolimus Eluting Coronary Stent Sales Market Share by Type (2017-2028)
    Figure 38. North America Sirolimus Eluting Coronary Stent Sales Market Share by Application (2017-2028)
    Figure 39. North America Sirolimus Eluting Coronary Stent Sales Market Share by Country (2017-2028)
    Figure 40. North America Sirolimus Eluting Coronary Stent Revenue Market Share by Country (2017-2028)
    Figure 41. United States Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Canada Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Mexico Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Europe Sirolimus Eluting Coronary Stent Sales Market Share by Type (2017-2028)
    Figure 45. Europe Sirolimus Eluting Coronary Stent Sales Market Share by Application (2017-2028)
    Figure 46. Europe Sirolimus Eluting Coronary Stent Sales Market Share by Country (2017-2028)
    Figure 47. Europe Sirolimus Eluting Coronary Stent Revenue Market Share by Country (2017-2028)
    Figure 48. Germany Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. France Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. United Kingdom Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Russia Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Italy Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Market Share by Region (2017-2028)
    Figure 54. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Market Share by Application (2017-2028)
    Figure 55. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Market Share by Region (2017-2028)
    Figure 56. Asia-Pacific Sirolimus Eluting Coronary Stent Revenue Market Share by Region (2017-2028)
    Figure 57. China Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Japan Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Korea Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. India Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Southeast Asia Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Australia Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. South America Sirolimus Eluting Coronary Stent Sales Market Share by Type (2017-2028)
    Figure 64. South America Sirolimus Eluting Coronary Stent Sales Market Share by Application (2017-2028)
    Figure 65. South America Sirolimus Eluting Coronary Stent Sales Market Share by Country (2017-2028)
    Figure 66. South America Sirolimus Eluting Coronary Stent Revenue Market Share by Country (2017-2028)
    Figure 67. Brazil Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Argentina Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Market Share by Type (2017-2028)
    Figure 70. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Market Share by Application (2017-2028)
    Figure 71. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Market Share by Region (2017-2028)
    Figure 72. Middle East & Africa Sirolimus Eluting Coronary Stent Revenue Market Share by Region (2017-2028)
    Figure 73. Turkey Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Egypt Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Saudi Arabia Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. South Africa Sirolimus Eluting Coronary Stent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Manufacturing Cost Structure Analysis of Sirolimus Eluting Coronary Stent in 2021
    Figure 78. Manufacturing Process Analysis of Sirolimus Eluting Coronary Stent
    Figure 79. Sirolimus Eluting Coronary Stent Industrial Chain
    Figure 80. Sales Channel: Direct Channel vs Indirect Channel
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Cardionovum
Concept Medical
BIOTRONIK
Terumo Europe
Meril Life Sciences
eucatech AG
Eurocor Tech
MedAlliance
Boston Scientific
Abbott
Vasmed
Alvimedica
B. Braun
Balton

Related Reports

Global Sirolimus Eluting Coronary Stent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Sirolimus Eluting Coronary Stent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 04 Aug 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Sirolimus Eluting Coronary Stent market size was valued at USD 105 million in 2022 and is forecast to a readjusted size of USD 132.2 million by 2029 with a CAGR of 3.3% during review period.

Global Sirolimus Eluting Coronary Stent Supply, Demand and Key Producers, 2023-2029

Global Sirolimus Eluting Coronary Stent Supply, Demand and Key Producers, 2023-2029

date 04 Aug 2023

date Medical Devices & Consumables

The global Sirolimus Eluting Coronary Stent market size is expected to reach $ 132.2 million by 2029, rising at a market growth of 3.3% CAGR during the forecast period (2023-2029).

Global Sirolimus Eluting Coronary Stent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Sirolimus Eluting Coronary Stent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 04 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Sirolimus Eluting Coronary Stent market size was valued at USD 105 million in 2023 and is forecast to a readjusted size of USD 132.2 million by 2030 with a CAGR of 3.3% during review period.

Global Sirolimus Eluting Coronary Stent Supply, Demand and Key Producers, 2024-2030

Global Sirolimus Eluting Coronary Stent Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Medical Devices & Consumables

The global Sirolimus Eluting Coronary Stent market size is expected to reach $ 132.2 million by 2030, rising at a market growth of 3.3% CAGR during the forecast period (2024-2030).

Product Tags

sirolimus eluting coronary stent

Sirolimus Eluting Coronary Stent System

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>